These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2357587)

  • 21. Genetic differences in morphine sensitivity, tolerance and withdrawal in rats.
    Hoffmann O; Plesan A; Wiesenfeld-Hallin Z
    Brain Res; 1998 Sep; 806(2):232-7. PubMed ID: 9739144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid induction of dependence to morphine in rats.
    Leung CM; Dai S; Ogle CW
    Neuropharmacology; 1986 Mar; 25(3):305-7. PubMed ID: 3703178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain.
    Kandasamy R; Lee AT; Morgan MM
    Pharmacol Biochem Behav; 2017 May; 156():10-15. PubMed ID: 28366799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of spontaneous morphine withdrawal symptoms in rats.
    van der Laan JW; van 't Land CJ; Loeber JG; de Groot G
    Arch Int Pharmacodyn Ther; 1991; 311():32-45. PubMed ID: 1789712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine preference in rats previously morphine dependent.
    Dai S; Hui SC; Ogle CW
    Pharmacol Res Commun; 1984 May; 16(5):495-511. PubMed ID: 6539922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary sensory neurones and naloxone-precipitated morphine withdrawal.
    Donnerer J
    Br J Pharmacol; 1989 Apr; 96(4):767-72. PubMed ID: 2472843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes.
    Kim DH; Fields HL; Barbaro NM
    Brain Res; 1990 May; 516(1):37-40. PubMed ID: 2163724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
    Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
    Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of morphine withdrawal and quasi-abstinence syndrome in a model of chronic pain in the rat.
    Lérida M; Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1987 Oct; 81(1-2):155-8. PubMed ID: 3696464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of morphine tolerance and dependence in scopolamine-treated rats.
    Zhou H; Ge X; Wang LZ; Ma L; Pei G
    Neuroreport; 1999 Jul; 10(10):2007-10. PubMed ID: 10424665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspects of abstinence after morphine ingestion.
    Rönnbäck L; Eriksson PS; Zeuchner J; Rosengren L; Wronski A
    Pharmacol Biochem Behav; 1987 Sep; 28(1):87-93. PubMed ID: 3659110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal pertussis toxin attenuates the morphine withdrawal syndrome in normal but not in arthritic rats.
    Lérida M; Garzón J; Sánchez-Blázquez P
    Life Sci; 1990; 46(5):329-34. PubMed ID: 2304375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
    Ozdoğan UK; Lähdesmäki J; Scheinin M
    Eur J Pharmacol; 2003 Jan; 460(2-3):127-34. PubMed ID: 12559372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of environmental enrichment on physical and psychological dependence signs and voluntary morphine consumption in morphine-dependent and morphine-withdrawn rats.
    Hammami-Abrand Abadi A; Miladi-Gorji H; Bigdeli I
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):270-8. PubMed ID: 26397757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.